With open source technologies, the license fee for proprietary systems is no longer a barrier entry for small and mid-size pharmaceutical, biotechnology and medical device companies
Sunnyvale, CA (PRWEB) December 05, 2011
Clinovo features in leading pharmaceutical media with its article that describes how open source technologies help streamline the clinical trial process. The article demonstrates how open source technology presents an innovative solution to the challenging pharmaceutical and biotechnology industries, and ultimately helps life science companies bring their medical innovations faster to patients. The paper goes over the benefits of open source technologies for the clinical trial process, and describes the major open source clinical data management systems available on the market. Read more
Clinical trials have become increasingly complex and, as a result, costly. Only 333 drugs and biologics have been approved between 2000 and 2010 due to stricter regulatory procedures while spending has increase by 15 in the same period of time.
The need for innovation is critical in the pharmaceutical and biotechnology industry. Life science companies and service providers are looking for innovative solutions to improve study performance and minimize their risks.
This article demonstrates how open source technology presents an innovative solution to this challenging environment, and ultimately helps bring medical innovations faster to patients. Read the article in Clinical Leader
What is open source?
Open Source in the Clinical Trial Industry
Benefits of open source technologies for clinical trials
A rising trend: Open source for electronic data capture
The emergence of open source based tools for CDISC conversion